Active substance
Hydrogen peroxide
- US FDA 1
- US price lines 5
- NHS prices 3
- Safety 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ESKATA | 40% | solution · topical | ACLARIS | Discontinued | 14 Dec 2017 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | FT HYDROGEN PEROXIDE 3% SOLN | $0.01814 | per ML | 22 Apr 2026 |
| US NADAC | GNP HYDROGEN PEROXIDE 3% SOLN | $0.01814 | per ML | 22 Apr 2026 |
| US NADAC | HYDROGEN PEROXIDE 3% SOLUTION | $0.01814 | per ML | 22 Apr 2026 |
| US NADAC | HYDROGEN PEROXIDE 3% SOLUTION | $0.00634 | per ML | 23 Sep 2026 |
| US NADAC | HYDROGEN PEROXIDE 3% SOLUTION | $0.00153 | per ML | 23 Sep 2026 |
| NHS Drug Tariff | Hydrogen peroxide 1% cream | £8.07 | 25 gram | 1 Oct 2026 |
| NHS Drug Tariff | Hydrogen peroxide 1% cream | £11.62 | 40 gram | 1 Oct 2026 |
| NHS Drug Tariff | Hydrogen peroxide 1.5% mouthwash sugar free | £2.94 | 300 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 7 Feb 2019 ESKATA — safety-related labeling change
Labeling sections changed: Adverse Reactions - MHRA 19 Dec 2014 Hydrogen peroxide: reminder of risk of gas embolism when used in surgery
Do not use in closed body cavities or on deep or large wounds.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.